Latest Insider Transactions at Nuvectis Pharma, Inc. (NVCT)
This section provides a real-time view of insider transactions for Nuvectis Pharma, Inc. (NVCT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Nuvectis Pharma, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Nuvectis Pharma, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 04
2022
|
Shay Shemesh Chief Dev. & Ops. Officer |
BUY
Open market or private purchase
|
Direct |
2,100
+0.18%
|
$6,300
$3.38 P/Share
|
|
Feb 04
2022
|
Enrique Poradosu Chief Science & Business Off |
BUY
Open market or private purchase
|
Direct |
3,800
+0.32%
|
$11,400
$3.35 P/Share
|